Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Manufactures and sells pharmaceuticals

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Sanovel Ila�� Sanayi ve Ticaret AS engages in the manufacture of pharmaceutical products. It develops medicaments, such as antihistamines, expectorants, decongestants, antibiotics, and anti-inflammatory drugs, as well as offers research and development services. The company was founded by Erol Toks��z in 1983 and is headquartered in Istanbul, Turkey.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Part of Altria Group, Inc., General Foods Corp. is an American company located in Orlando, FL, that processes & markets packaged grocery & meat products. It was acquired by Altria Group, Inc. on September 25, 1985 for $5,627.64 million.

Shanghai Yahong Pharmaceutical Technology Co., Ltd., established on 2017-11-17, Business scope includes general items:Engaged in technology development in the field of medical technology,technical consulting,Technical Services,technology transfer(human stem cells,Except for the development and application of genetic diagnosis and treatment technology);Engaged in the import and export of goods and technology;Intellectual property agency;Business Consulting;Planning of cultural and artistic exchange activities(show manager,Except for commercial performances);Business Management Consulting;Expo Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Jiangsu Yahong Meditech Co., Ltd. engages in the research, development, production and commercialization of medicines in the fields of urogenital system tumors and other major diseases fields. It provides patients with integrated solutions for diagnosis and treatment. The company's products include APL-1202, APL-1501, APL-1706, APL-1702, ASN-1764, ASN-1780, APL-1901, APL-1401, and ASN-1733. Jiangsu Yahong Meditech was founded by Ke Pan and Cheng Rui Zhuang on March 16, 2010 and is headquartered in Shanghai, China.

Sandoz AG, part of Novartis AG, is a company headquartered in Basel, Switzerland, that develops generic medicines and biosimilars.

Mayne Pharma International Pty Ltd., part of Mayne Pharma Group Ltd., is an Australian company. The firm manufactures and distributes pharmaceutical products. It was acquired by Halcygen Pharmaceuticals Ltd. from Hospira, Inc. on October 30, 2009 for $15.00 million.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Manufactures, marketes and imports, exports pharmaceutical drugs

Paratek Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry. Paratek's lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed in both oral tablet and intravenous formulations for use as a first-line monotherapy antibiotic for ABSSSI, CABP, urinary tract infections (UTI) and other serious community-acquired bacterial infections, particularly when antibiotic resistance is of concern to prescribing physicians. Omadacycline has received Qualified Infectious Disease Product (QIDP) designation by the U.S. Food and Drug Administration for both the oral and intravenous formulations in all three of these infectious disease categories. Paratek has Special Protocol Assessment agreements with the FDA for the phase 3 trials planned in ABSSSI and CABP.

These words reflects the company's mission statement since its inception in 1988 and will continue to do so in the coming future. Each and every word in the mission statement has been carefully choosen to reflect our company strategy in order to live up to the expectations and standards envisioned by it. Tough competition by market globalization drives us to deliver high quality products through innovation that encapsulates new ideas and collaboration to encourage creativity. In addition, Farenheit is seeking to expand its lineup by seeking collaboration with partners overseas to develop and distribute licensed new products. Partnership like these allows the construction of distribution networks for the company which can provide us with new opportunities to expand beyond the local market. Together with our local products, Fahrenheit is able to deliver new products and concepts to provide customers with products that meet their needs, keeping in mind the mission statement.

J. Rettenmaier & Söhne GmbH + Co. KG manufacture and distribute cellulosic fiber products. Its products include apple and bamboo fibers, broken pellets, cellulose fibers, additives, powder, derivatives, compounds, flour, pellets, granules and compactate, croscarmellose sodium, colloidal systems, corn fluff, MCC-Pellets, natural fiber, oat fibre, psyllium, premix, raw fiber concentrates, soft wood fibers, wheat fibres and wood flour. The company was founded by Jakob Rettenmaier in 1878 and is headquartered in Rosenberg, Germany.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Anhui Sunhere Pharmaceutical Excipients Co., Ltd. engages in the research and development, production, and sale of pharmaceutical excipients. Its products include fillers, binders, disintegrants, lubricants, and coating materials. The company was founded on April 27, 2001 and is headquartered in Huainan, China.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.